Bayesian hierarchical models that characterize the distributions of (transformed) gene profiles have been proven very useful and flexible in selecting differentially expressed genes across different types of tissue samples (e.g. Lo and Gottardo, 2007) . However, the marginal mean and variance of these models are assumed to be the same for different gene clusters and for different tissue types. Moreover, it is not easy to determine which of the many competing Bayesian hierarchical models provides the best fit for a specific microarray data set. To address these two issues, we propose a marginal mixture model that directly models the marginal distribution of transformed gene profiles. Specifically, we approximate the marginal distributions of transformed gene profiles via a mixture of three-component multivariate Normal distributions, each component of which has the same structures of marginal mean vector and covariance matrix as those for Bayesian hierarchical models, but the values can differ. Based on the proposed model, a method is derived to select genes differentially expressed across two types of tissue samples. The derived gene selection method performs well on a real microarray data set and consistently has the best performance (based on class agreement indices) compared with several other gene selection methods on simulated microarray data sets generated from three different mixture models.
Introduction
Microarray technology allows simultaneous measurement of the expression levels of thousands of genes within a biological tissue sample. By comparing the arrays of different types of tissue samples (e.g., abnormal versus normal), researchers can investigate the joint effects of groups of genes on diseases. This information may help develop methods to diagnose, or even cure, diseases. An important step in the analysis of microarray data is to identify genes differentially expressed across types of tissue samples. Powerful gene selection helps pinpoint genes affecting disease status.
Microarray data are so-called high-dimensional-low-sample-size data, because the number of genes (variables) is far bigger than the number of tissue samples (data points). Hence conventional variable selection methods cannot be directly applied to select differentially expressed genes. One common gene selection approach is to first invoke a statistical hypothesis test (e.g., two-sample t-test or Wilcoxon test) for each gene, and then to claim that genes are differentially expressed if the corresponding p-values of the tests fall below a threshold. A potential limitation of this approach is that the variance estimates might be unstable due to small sample size. Several approaches have been proposed to stabilize the variance estimates for the two-sample t-test (e.g. SAM, proposed by Tusher et al. (2001) ). Another potential limitation is the so-called multiple testing problem. One remedy is to adjust p-values of the tests so that family-wise error rate (FWER) or false-discovery rate (FDR) is controlled.
Instead of adjusting p-values, Efron et al. (2001) directly modeled the distribution of the summary statistics (e.g. two-sample t-test statistics) of gene profiles via a mixture of two-component univariate distributions. One component of the mixture of distributions corresponds to the distribution of summary statistics for differentially expressed genes. The other corresponds to the distribution of summary statistics for nondifferentially expressed genes. The gene-cluster membership is then determined based on the posterior probability that a gene belongs to a cluster given its summary statistic. An advantage of this approach is that multiple testing is not involved, and information from a large number of genes can be used. Publications by Pan (2002) , He (2004) , Do et al. (2005) , and McLachlan et al. (2006) also discussed this approach. Broët et al. (2002) extended this approach by proposing a summary statistic that can detect different levels of gene expression changes. Broët et al. (2004) later improved Broët et al. (2002) to handle more than two classes of tissue samples. Lee et al. (2000) viewed the microarray data from a different angle: regarding gene profiles as data points and tissue samples as variables, allowing microarray data to be viewed as low-dimensional-large-sample-size data. Lee et al. (2000) and its extension (Lee et al., 2002) directly modeled the distributions of the gene profiles by a mixture of two-component multivariate distributions. Gene-cluster membership can then be determined by the posterior probability that a gene belongs to a gene cluster given its profile. Multiple testing is not involved in this approach. Moreover, information could be borrowed across genes, hence this approach has the potential to perform well even for a small number of tissue samples. One potential limitation of this approach is the assumption that different genes in the same cluster have the same conditional mean vectors and covariance matrices.
Modeling component distributions by hierarchical distributions allows more flexible models that have different conditional mean vectors and covariance matrices for genes in the same cluster. Several such Bayesian hierarchical models have been proposed, such as GG (Gamma-Gamma) (Newton et al. 2001) , LNN (LogNormal-Normal) (Kendziorski, et al, 2003) , eGG (extended GG) (Lo and Gottardo, 2007) , and eLNN (extended LNN) (Lo and Gottardo, 2007) .
We observed that Bayesian hierarchical models have special structures of marginal mean vectors and covariance matrices (see Appendix A). Specifically, the marginal means and variances of gene expression levels for different tissue types are assumed to be the same. It is possible to allow Bayesian hierarchical models to have tissue-type specific hyperparameters so that we can distinguish the marginal meanvector and covariance-matrix structures of different tissue types. However, it would be difficult to interpret these hyperparameters. Moreover, different choices of the conditional distribution and prior distribution will result in different Bayesian hierarchical models. This raises the question of which model is the "best" for a given set of microarray data. Moreover, when one applies Bayesian hierarchical models, the marginal distributions have to be derived first to calculate the posterior probability that a gene belongs to a gene cluster given its profile (e.g. Lo and Gottardo, 2007) . Sometimes these marginal distributions are not easy to derive. Furthermore, in practice investigators are usually interested in a three-cluster partition of genes: genes over-expressed in abnormal tissue samples, genes non-differentially expressed, and genes under-expressed in abnormal tissue samples.
These observations motivate us to propose a new model that (1) allows tissuetype-specific hyperparameters; and (2) explicitly distinguishes between genes overexpressed and underexpressed in abnormal tissue samples. Most importantly, instead of constructing Bayesian hierarchical models, we directly model the marginal distributions of transformed gene profiles. Specifically, we approximate the marginal distributions of transformed gene profiles via a mixture of three-component multivariate Normal distributions, each component of which has the same structures of mean-vector and covariance-matrix as those of Bayesian hierarchical models. We call this the marginal mixture model (MMD).
The remainder of this article is structured as follows. In Section 2, we describe MMD, derive a gene selection method, and present estimation formulae of several error rates for real microarray data sets. In Section 3, we use a real microarray data set to illustrate MMD. In Section 4, we use simulated microarray data sets generated from three different mixture models to assess the performance of the proposed MMD framework. We will use the same names of the mixture models to refer to gene selection methods based on mixture models. Finally we comment on the proposed framework and possible extensions in Section 5.
Marginal mixture model
, a m × 1 vector, be the transformed gene profile for a randomly selected gene over m tissue samples (m = m c + m n , where m c is the number of abnormal tissue samples and m n normal tissue samples). We assume that data have been normalized to remove the effects of confounding factors, such as dye effect, chip effect, batch effect, etc.. The distribution of X is assumed to be a three-component mixture of multivariate Normal distributions with marginal density:
where π 1 , π 2 , π 3 are mixture proportions. The m × 1 vector x is a realization of the random vector X; θ k , is the parameter set for the k-th component distribution f k , k = 1, 2, 3; and f 1 , f 2 , and f 3 are the density functions for multivariate Normal distributions with the mean vectors
and covariance matrices
respectively, where correlation matrix
of the random vector X are for the abnormal tissue samples and the remaining m n elements are for the normal tissue samples. Let
Note that µ c 1 > µ n 1 for component 1 in which genes are overexpressed in abnormal tissue samples, and µ c 3 < µ n 3 for component 3 where genes are underexpressed in abnormal samples. Our prior belief is that the majority of genes are usually non-differentially expressed, so we assume π 2 > π 1 and π 2 > π 3 .
Model (1) assumes that (a) marginal means and variances of expression levels for a given gene from the same type of tissue samples are the same; (b) marginal correlations between any pair of expression levels for a given differentially expressed gene from the same type of tissue samples are the same; (c) marginal correlations between any pair of expression levels for a given gene from different types of tissue samples are zero; (d) gene profiles in the same gene cluster have the same marginal distributions; and (e) gene profiles are marginally independent. These assumptions capture the structural information of microarray data. For instance, tissue samples of the same type are usually assumed to be from the same population and hence have the same marginal distribution; tissue samples of different types are usually assumed to be from different populations and hence marginally independent. These assumptions are commonly imposed on microarray data to characterize their structure (e.g., Newton et al, 2001; Kendziorski et al, 2003; Lo and Gottardo, 2007) .
We would like to emphasize that MMD could approximate a wide range of Bayesian hierarchical models, including those that allow both gene-specific conditional means and gene-specific conditional variances, as long as we can find appropriate transformations to transform the distribution of gene expression levels close to a Normal distribution.
In practice, transforming data (e.g., natural logarithm transformation) is routine in the analysis of microarray data to stabilize variation of gene expression levels and to obtain desirable statistical properties, such as normality (Lee, 2004) . We use the Box-Cox transformation (Box and Cox, 1964) , which includes natural logarithm transformation as a special case. Although Box-Cox transformation, which is a family of power transformations, cannot always transform a non-Normal distribution to an exact Normal distribution, Draper and Cox (1969) pointed out that "the transformation estimated will correspond to a distribution . . . that is usually to a nearly symmetrical distribution." We apply the same Box-Cox transformation for all gene expression levels. Appendix B gives details on how we choose Box-Cox transformation based on a QQ-plot, which is a common tool to assess normality of data.
To make gene clusters tighter and more isolated, gene-profile scaling is recommended after Box-Cox transformation so that expression levels of each gene have mean zero and variance one. After Box-Cox transformation and gene-profile scal-ing, the within-cluster gene profile variation tends to be smaller than the betweencluster gene profile variation, and the marginal distribution of expression levels for non-differentially expression genes would be close to the standard Normal distribution N (0, 1).
From Model (1), a gene selection method can be derived. The i-th gene is assigned to one of the three clusters based on its posterior probability
where x i is the (transformed) profile for the i-th gene, i = 1, . . . , p. Specifically, we classify gene i with profile x i to cluster C k 0 if the posterior probability that the i-th gene belongs to cluster C k 0 given x i is the largest, i.e.,
The estimatesθ k , k = 1, 2, 3 can be obtained via the EM algorithm (Dempster et al, 1977) . More details are shown in Appendix C. It is well-known that the EM algorithm may be sensitive to the choice of initial values of model parameters, so several different initial values are often used, choosing the final result that maximizes the likelihood function. We use two initial sets of model parameters. One is based on gene-wise t-tests; the other is based on a model-based clustering (Mclust) algorithm (Freely and Rafters, 1999) . Details are given in Appendix D. The stopping criterion is given in Appendix E.
Several error rates have been proposed to assess the performance of a gene selection method from different perspectives, including FDR (the percentage of nondifferentially expressed genes among selected genes), FNDR (the percentage of differentially expressed genes among unselected genes), FPR (the percentage of selected genes among nondifferentially expressed genes), and FNR (the percentage of un-selected genes among differentially expressed genes). It is challenging to estimate these error rates for real data sets, because whether a gene is differentially expressed is usually unknown. One approach to estimating these error rates for real microarray data sets is the model-based approach, which first models the distribution of gene profiles, test statistics, or transformed p-values, then derives the theoretical formulae for the error rates, and finally uses in the estimates of the unknown parameters in the formulae (e.g., Efron et al. 2001; Efron, 2004; Pakistan et al. 2005; McLachlan et al. 2004 McLachlan et al. , 2006 . Based on Model (1) and the gene selection criterion (6), the formulae of FDR, FNDR, FPR, and FNR for MMD can be derived as:
, where C 2 denotes the cluster of nondifferentially expressed genes. While the above probabilities are analytically intractable, we can estimate these probabilities based on the results from McLachlan et al. (2004) :
where I A is the indicator function, which is one if event A is true and zero otherwise.
Example
In this section we use a publicly available real microarray data set, initially studied in Golub et al. (1999) , to illustrate MMD. The Golub data set we use consists of 3, 051 gene profiles over 11 acute myeloid leukemia tissue samples (denoted as AML and regarded as abnormal in MMD) and 27 acute lymphoblastic leukemia samples (denoted as ALL and regarded as normal in MMD), pre-processed by the method described in Dudoit et al. (2002) . The upper panel of Figure 1 shows the histograms of expression levels for AML samples and ALL samples. The histograms in the lower panel show that the Box-Cox transformation and gene-profile scaling transformed the non-normal Golub data close to Normal.
The parameter estimates by MMD are: well (see the lower panel of Figure 1 ). Table 1 shows the mean posterior probabilities to belong to classes 1, 2 or 3 in each posterior class, indicating that the overlap between cluster 1 and cluster 3 is small and there is some overlap between cluster 1 and cluster 2 and between cluster 2 and cluster 3.
To study the performance of MMD relative to other gene selection methods, we compare MMD with the empirical Bayesian method (denoted as EB), gene selection methods based on GG, LNN, eGG, and eLNN models, and two methods we used to generate initial values of MMD model parameters: one is a gene-wise Ttest (denoted as gwTtest), and the other is based on Mclust (Fraley and Raftery, 1999) . We designated this revised Mclust as rMclust.
We perform Box-Cox transformation and gene-profile scaling before applying MMD, gwTtest, and rMclust. We apply EB for both untransformed and transformed data, and designate the two approaches as EB and EB.t, respectively. We apply GG, eGG, LNN, and eLNN directly to the original data set. For this real data set, we follow the example of Efron (2001) , using use 0.90 as the cutoff for (rMclust) . The large estimated proportions (0.3 − 0.4) are probably because (a) acute leukemias are complex diseases, hence many genes might be involved; and (b) there are "borderline" genes, the cluster memberships of which are not clear-cut (see also the Discussion Section). It is interesting that (1) MMD identified more genes as differentially expressed than other methods did; (2) more genes were identified as differentially expressed by methods applied to transformed data (MMD, EB.t, gwTtest, rMclust) than by methods applied to untransformed data (GG, eGG, LNN, eLNN, EB). Because we do not know which genes are truly differentially expressed for the Golub data, it is hard to say which method performed best. In the next section, we will compare these gene selection methods via simulation study in which gene cluster memberships are known.
Simulation
In this section we consider three simulation scenarios based on three mixture models: MMD, GG, and LNN. The model parameter settings are based on the parameter estimates from the Golub data set using MMD, GG, and LNN models. For each scenario, we generate 100 simulated data sets. Each simulated data set contains 3, 200 gene profiles for 10 abnormal tissue samples and 10 normal tissue samples.
In scenario I, data sets are generated based on MMD with parameters
In scenario II, data sets are generated from a mixture of 3-component LNN distributions. Its hyperparameter values are based on the estimated hyperparameters of Kendziorski, et al's (2003) Because we know the true gene membership for simulated data sets, we estimate error rates by directly comparing the true gene membership with the gene membership obtained by gene selection methods. For example, FNR is estimated by the ratio of the number of unselected genes among differentially expressed genes to the total number of differentially expressed genes for a simulated data set. We also measure the degree of agreement between the true gene-cluster membership and the gene-cluster membership estimated by a gene selection method based on five agreement indices investigated in Milligan (1986) : Rand index, Hubert and Arabie's adjusted Rand index (HA), Morey and Agresti's adjusted Rand index (MA), Fowlkes and Mallows's index (FM), and Jaccard index, where HA and MA take chance agreement into account. For perfect agreement, the values of these five agreement indices are equal to one. We estimate the error rates and agreement indices by the averaged error rates over 100 simulated data sets in each scenario. Wald-type 95% confidence interval (CI) can also be constructed based on error rates for the 100 simulated data sets for each scenario.
Since data sets in Scenario I will be directly generated from the MMD model, we do not perform Box-Cox transformation and gene-profile scaling before applying MMD, gwTtest, and rMclust for data sets in Scenario I. When applying EB and EB.t, cutoffs like 0.5, 0.6, 0.7, 0.8, 0.9, 0.95 for posterior probability are used. When applying GG, eGG, LNN, and eLNN, FDR cutoffs like 0.01, 0.05, 0.1, 0.15 and 0.2 are used.
The estimated error rates, agreement indices, and their Wald-type 95% CIs are summarized in Figures 2 -7 . For all three scenarios, MMD has the highest values for the estimated agreement indices. Although its 95% CIs are usually wider than those of other gene selection methods, in most of cases, they do not overlap with those of other methods. In terms of error rates, MMD has small (< 0.2) estimated FDR, FNDR, FPR, and FNR, while other methods have at least one estimated error rates over 0.2 for at least one scenario.
Like MMD, the performance of gwTtest, EB, and EB.t are quite stable across the three scenarios. The performance of gwTtest is close to that of MMD for scenario I, but is worse than EB and EB.t for scenarios II and III. The performances of EB and EB.t depend on cutoff values. As the cutoff increases, the estimated agreement indices, FNDR, and FNR of EB and EB.t increase for all three scenarios, while the estimated FDR and FPR decrease, except that the estimated agreement indices first increase and then decrease in scenario I. The similarity in performance of EB and EB.t indicates that the empirical Bayesian method is quite robust to the departure from the normality assumption.
For data sets generated in scenario I, rMclust performs well. However, for data sets generated in scenarios II and III, it performs poorly. This is probably because Mclust is designed to find patterns in gene profiles. Additionally, the patterns detected do not necessarily match clusters of differentially expressed genes and clusters of non-differentially expressed genes (see also the Discussion section).
Like EB and EB.t, the performance of GG, eGG, LNN, and eLNN depend on cutoff values. For scenario I, GG, eGG, LNN, and eLNN with FDR cutoff ≥ 0.1 identified almost all genes as differentially expressed. Even for FDR cutoffs 0.01 and 0.05, their performance was worse than other methods. For scenarios II and III, the agreement indices, FNDR, and FNR for GG, eGG, LNN, and eLNN decrease as cutoff increases, while FDR and FNR increase as cutoff increases, except that Rand, FM, and Jaccard of eGG for scenario II first decrease, then increase. For scenarios II and III, the performances of GG, eGG, LNN, and eLNN with cutoff 0.01 are close to that of MMD and are better than those of gwTtest, rMclust, EB, and EB.t.
It is important to evaluate the proposed method when the inter-gene variance increases (τ 2 0 in 3-component LNN model or ν in 3-component GG model). We tried two different τ 0 values (0.1 and 1) for the three-component LNN model. The marginal correlations are 0.5 and 0.91, respectively. We kept the marginal means unchanged. We also tried two different ν values (10 and 100) for the threecomponent GG model. The marginal variances changed to 63.44 and 6343.732, respectively. The marginal correlations were unchanged. To make sure µ c 1 −µ n 1 = µ n 3 − µ c 3 = 1.5σ, we set µ c 1 = 24, µ n 1 = 12.05, µ 2 = 18.79, µ c 3 = 12.82, µ n 3 = 24.77 for ν = 10, and µ c 1 = 247, µ n 1 = 127.53, µ 2 = 187.93, µ c 3 = 128.20, µ n 3 = 247.67 for ν = 100. The patterns of estimated error rates and agreement indices (not shown) are the same as those in Figure 2 -7.
In general, the proposed MMD consistently performed best for the simulated 
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The International Journal of Biostatistics, Vol. 4 [2008] , Iss. 1, Art. 20 DOI: 10.2202 /1557 -4679.1093 data sets in these three scenarios, because (1) it has the highest estimated agreement indices for all three scenarios; and (2) its estimated error rates are smaller than 0.2 for all three scenarios, while the other methods have at least one estimated error rate over 0.2 for at least one scenario.
Discussion
We propose a new mixture model (MMD) designed to directly characterize the marginal distributions of gene profiles, grouping genes into three clusters: genes over-expressed in abnormal tissues, genes non-differentially expressed, and genes under-expressed in abnormal tissues. Combined with appropriate data transformation, MMD can be used to approximate many mixture models imposed on microarray data. MMD makes efficient use of the structural information of microarray data and has interpretable model parameters. MMD does not involve multiple testing, because no hypothesis testing is performed. MMD performs well on the publicly available Golub microarray data set and consistently has the best performance compared to other gene selection methods we considered for the simulated data sets generated from three different mixture models in terms of the five agreement indices (Rand, HA, MA, FM, Jaccard).
Choosing an appropriate method of data transformation is important to the success of MMD. Hence we use a combination of the Box-Cox transformation and the gene-profile scaling if the histogram of all expression levels for either type of tissue samples looks skewed. For the real data set and simulated data sets studied in this article, this combined transformation works well. This confirms Yeung et al.'s (2001) conclusion that suitably chosen transformations seem to result in reasonable fits of microarray data by multivariate Normal distributions. Further research is required to investigate when the combined transformation can work well and what alternative options we have when it does not work well. For example, we expect that MMD with the combined transformation might not work well for heavy-tailed data and/or data containing outliers. In these cases, data sharpening techniques (e.g., Choi and Hall, 1999; Wang et al. 2007 ) may be used. For example, the eGG and eLNN models proposed by Lo and Gottardo (2007) relaxed the assumption of a constant coefficient of variation across genes required by the GG and LNN models, by imposing a prior distribution to the rate parameter of GG model and the variance of LNN model. Hence we expect more variability for the marginal distributions of eGG and eLNN models. In fact, it can be shown that the marginal kurtosis of eLNN model is 3/(α − 2), where a random expression level Y ij in eLNN model has the following hierarchical structure:
If α is close to 2, then the marginal kurtosis will be very large, hence the tail of the marginal distribution will be heavy. In this case, we might apply data sharpening techniques before applying MMD.
Model (1) requires the assumption that gene profiles are marginally independent of each other, as assumed by other similar models (e.g., Efron et al., 2001; Lo and Gottardo, 2007) . However, gene profiles may be marginally correlated in real situations, as many genes may function together in the same pathway. We will investigate this issue in future research.
We expect that in some cases, classification of some genes will not be straightforward. The magnitude of separation between any two of the three clusters can be evaluated by separation indices (e.g., Qiu and Joe, 2006) . Moreover, based on the posterior probabilities produced by MMD, it might be useful to divide the genes further into 5 or 6 clusters such as: a) strongly overexpressed, b) strongly underexpressed, c) borderline overexpressed, d) borderline underexpressed, e) not expressed, and f) borderline not expressed.
Finally, we would like to point out that MMD is different from typical gene clustering methods such as Mclust (Yeung et al. 2001) , in that MMD aims to detect three specific gene clusters (genes over-expressed in abnormal tissue samples, genes non-differentially expressed, genes under-expressed in abnormal tissue samples), while typical gene clustering aims to detect any possible patterns of clustering in the data. The number of clusters is usually unknown and needs to be estimated in typical gene clustering. Even if we specify the number of clusters as three for typical gene clustering, the patterns detected do not necessarily match the clusters of differentially expressed genes and non-differentially expressed genes. Moreover, the gene clusters detected by typical gene clustering methods do not necessarily have the same structures for the marginal mean vectors and covariance matrices as those shown in Formulae 2 and 3.
The eLNN model assumes that 100π% percent genes are differentially expressed and 100(1−π)% percent genes are non-differentially expressed. For the g-th differentially expressed gene, its profiles can be characterized by the following Bayesian hierarchical model:
where α is the shape parameter and β is the rate parameter, or equivalently, 1/β is the scale parameter. For the g-th non-differentially expressed gene, its profiles can be characterized by the following Bayesian hierarchical model:
Here we assume that, given higher-level hyperparameters, the current level parameters or data are conditionally independent.
Based on the smoothing formulae
where Y , Y 1 , Y 2 , and θ are random variables, we can get the marginal mean and variance of ln (Y g, ), and get covariance and correlation between ln (Y g, ) and ln (Y g, ), = within each tissue type:
For non-differentially expressed genes, the above formulae for marginal covariance and correlation are still true for two tissue samples of different tissue types. We can show (see below) that for differentially expressed genes, the marginal covariance and correlation across tissue types are both zero. Hence the marginal mean vector and covariance matrix of the ln transformed profile of the g-th differentially expressed gene are
where
(13) The notation 1 mc represents a m c × 1 vector with all elements being one. I mc is the m c × m c identity matrix.
The marginal mean vector and covariance matrix of the ln transformed profile of the g-th non-differentially expressed gene are:
Now we show results for arbitrary 3-level hierarchical models. The results can be extended to models with more than three levels.
Without loss of generality, let y ij be the expression level of the i-th non-differentially expressed gene for the j-the abnormal tissue sample. Suppose
where η 0 , η 1 , and η 2 are the vectors of fixed hyperparameters.
Denote h 1 (δ 1i , η 1 ) = E (y ij |δ 1i , η 1 ) and h 2 (δ 1i , η 2 ) = Var (y ij |δ 1i , η 2 ). Based on the smoothing formulae (10) we can get E (y ij ) = E (h 1 (δ 1i , η 1 ) ) and Var (
That is, the marginal expectation E (y ij ) and the marginal variance Var (y ij ) do not depend on the subscript j, which indicates the j-th tissue sample. Similarly, we can show that the covariance Cov (y ij , y ik ) is the same for all j = k. In fact, Cov (y ij , y ik ) = Cov [h 1 (δ 1i , η 1 ), h 1 (δ 1i , η 1 )]. We assume that y ij and y ik are conditionally independent. By iteratively applying the smoothing formulae, one can further show that E (y ij ), Var (y ij ), and Cov (y ij , y ik ) depend only on the hyperparameters η 0 , η 1 , η 2 and do not depend on subscript i and j.
Now we want to show that for differentially expressed genes, between-tissuetype marginal covariance Cov (y ij,c , y ik,n ) = 0, where y ij,c is the expression level of the j-th abnormal tissue sample for gene i, and y ik,n is the expression level of the k-th normal tissue sample for gene i.
The last step is because the hyperparameters η 0 , η 1 , η 2 are fixed, not random. Here we assume that given higher-level hyperparameters, current level parameters are conditionally independent. ρ n 3 based on the genes that have p-values less than 0.05 and negative test statistics. To get the second initial set of model parameters, we first get a three-cluster partition of genes via Mclust, then calculate the likelihood function for each permutation of the cluster labels: 1, 2, 3. The permutation having the largest value of the likelihood function is chosen as the final three-cluster partition of genes, based on which the initial set of model parameters are estimated. If no permutation produces the partition such thatμ c 1 >μ n 1 andμ c 3 <μ n 3 , the initial set of parameters obtained by two-sample t-test will be used.
E The stopping criterion of the EM algorithm
In MMD, we stop EM if
or the iteration number exceeds the maximum allowed iteration number ITMAX. For the analyses of the real data set and simulated data sets in this article, we set = 10
and ITMAX = 100. In the analyses of both real and simulated data in this article, the total number of iterations were less than ITMAX = 100. For the real data set, the total number of iterations corresponding to the two initial sets of parameters are both 10. Table  2 lists the median and range of the total number of iterations in the analysis of the data sets used in this article. Titterington et al. (pages 88-89, Section 4.3.2, 1995) pointed out that (1) unconditional convergence of the parameter estimates via EM to maximum likelihood estimate is not guaranteed. This is true also for other alternative algorithms such as the Newton-Raphson method and the method of scoring; (2) the convergence of EM is often "excruciatingly slow" compared to alternative algorithms, such as the
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The International Journal of Biostatistics, Vol. 4 [2008] , Iss. 1, Art. 20 DOI: 10.2202 /1557 -4679.1093 Newton-Raphson method. However, EM is usually simple to apply and satisfies the appealing monotonic property (i.e., the likelihoods of interest increase monotonically as the iteration number increases). These are the main reasons that we chose the EM algorithm to obtain parameter estimates. It is possible that the values of f(x i |Ψ (t) ) are very close to zero for some x i . To increase the stability in numerical computation when we calculate w ij Ψ (t) in Formula (22), we rewrite Formula (22) as
3 ) / π
where 
